SCHEMBL742375

SCHEMBL742375

O=C(O)c1ccc(OB(O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.56
CA2 P00918 3/20 0.56
TSHR P16473 3/20 0.55
TP53 P04637 1/20 0.55
PARP15 Q460N3 1/20 0.50
PARP10 Q53GL7 1/20 0.50
KMT2A Q03164 1/20 0.50
SRD5A2 P31213 3/20 0.48
PKM P14618 1/20 0.48
HSD17B10 Q99714 1/20 0.47
CA12 O43570 1/20 0.46
CA3 P07451 1/20 0.46
TYR P14679 1/20 0.46
DRD1 P21728 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL31590444 0.98 CA1 (0.54) CA1CA2TSHRTP53PARP15
SCHEMBL28690614 0.98 CA1 (0.54) CA1CA2TSHRTP53PARP15
Ethylene SCHEMBL38650587 0.96 CA1 (0.52) CA1CA2TSHRTP53PARP15
SCHEMBL28920712 0.89 CA1 (0.50) CA1CA2TSHRTP53PARP15
SCHEMBL3458904 0.81 ELANE (0.58) KMT2ASRD5A2ALDH1A1LMNATDP1
SCHEMBL3604263 0.80 PARP10 (0.61) CA1CA2PARP15PARP10KMT2A
SCHEMBL28849890 0.80 ALDH1A1 (0.41) CA1CA2TSHRPARP15PARP10
SCHEMBL591298 0.80 MAPT (0.61) TSHRKMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL3800806 0.80 CA1 (0.38) CA1CA2TSHRKMT2ACA12
Terephthalic Acid SCHEMBL29375683 0.78 TSHR (0.63) CA1CA2TSHRTP53PARP15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122031401-A MOF-based drug delivery agent for multi-mechanism synergistic tumor treatment and preparation method thereof 理工清科(重庆)先进材料研究院有限公司 2026-05-15 CN claimed
US-12553868-B2 Kind of method for detecting sialoglycosyl casein glycomacropeptide JIANGNAN UNIVERSITY (CN) 2026-02-17 US claimed
CN-119368155-A Fluorescent boron quantum dot photocatalyst and preparation method and application thereof 南京工业大学 2025-01-28 CN claimed
CN-119055789-A Preparation method and application of multifunctional antibacterial nano delivery system 山东第一医科大学第一附属医院(山东省千佛山医院) 2024-12-03 CN claimed
CN-118900843-A Modified polyrotaxane containing boric acid 国立大学法人熊本大学 2024-11-05 CN claimed
CN-117165289-B Waterproof carbon quantum dot matrix composite phosphorescence material and preparation method thereof 太原理工大学 2024-10-29 CN claimed
CN-118766868-A SiRNA-loaded nano-composite and preparation method and application thereof 无锡市人民医院 2024-10-15 CN claimed
CN-118359661-A Flame-retardant curing agent and preparation method and application thereof 武汉理工大学 2024-07-19 CN claimed
CN-118085698-A High-temperature-resistant graphene anticorrosive paint and preparation method thereof 浙江鱼童新材料股份有限公司 2024-05-28 CN claimed
CN-116283758-B Method for synthesizing N-formyl tetrahydroquinoline from quinoline and product 安徽工业大学 2024-05-24 CN claimed
CN-118047813-A Responsive chemotherapeutic drug molecule based on boric acid ester bond and boron-nitrogen coordination bond and synthesis 华中科技大学 2024-05-17 CN claimed
CN-117982680-A Multi-site dendritic boric acid functionalized magnetic nano material and preparation method and application thereof 沈阳药科大学 2024-05-07 CN claimed
CN-117683530-A Nanometer cross-linking agent for ultralow-concentration guanidine gum and preparation method thereof 郑州德融科技有限公司 2024-03-12 CN claimed
US-20230204545-A1 KIND OF METHOD FOR DETECTING SIALOGLYCOSYL CASEIN GLYCOMACROPEPTIDE JIANGNAN UNIVERSITY (CN) 2023-06-29 US claimed
CN-116298266-A Sample pad treatment fluid, sample pad, sample detection fluid, test strip and detection kit for detecting gout marker CA72-4 光景生物科技(苏州)有限公司 2023-06-23 CN claimed
CN-109575315-B PVA supramolecular hydrogel and preparation method and application thereof 中国科学院大学 2021-12-24 CN claimed
US-8344158-B2 Fluorescent polymethine cyanine dyes WASHINGTON UNIVERSITY (US) 2013-01-01 US claimed
US-20090124792-A1 FLUORESCENT POLYMETHINE CYANINE DYES WASHINGTON UNIVERSITY IN ST. LOUIS (US) 2009-05-14 US claimed
JP-61083190-A None JP disclosed
JP-S6183190-A 2-(4'-SUBSTITUTED PHENYL)-5-ALKYL-1,3,2-DIOXABORINANE, ITS PREPARATION, AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME NITTO KASEI KK 1986-04-26 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124792-A1 FLUORESCENT POLYMETHINE CYANINE DYES CPNE4, CYB5R3, IK CA1 2651/4885CA2 1797/4885TSHR 4699/4885
US-12553868-B2 Kind of method for detecting sialoglycosyl casein glycomacropeptide BPGM, PTMS, SCAMP3 CA1 532/4885CA2 326/4885TSHR 2670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.